Coala Life announced that the US Food & Drug Administration (FDA) has cleared additional indications and uses for the Coala Heart Monitor. The new FDA 510k clearance enables the system to be used for auscultation and monitoring of patients' lungs remotely. The new functionality available is made immediately to existing and new users.

The new 510k clearance now allows caregivers to use the Coala Heart Monitor and its integrated stethoscope to also monitor and auscultate lungs remotely. The clearance broadens the intended use where the system with its cloud-based care portal can be used by care providers to help detect and monitor various types of lung and respiratory diseases. The new FDA-clearance also includes an enhanced ECG algorithm for automatic detection of Atrial Fibrillation (AF) based on RR-variability and P-wave analysis.